| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |